Coronary/Structural Heart

Cardio Diagnostics’ Whitepaper Examines Clinical Blind Spot in Coronary Heart Disease Detection and Care

Share by Ken Dropiewski on

More in Coronary/Structural Heart:

Share this story

CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics released a new whitepaper as a resource for clinicians navigating current limitations in detecting and managing NOCAD.

See the full post here as oringinally posted on this site.

Ken has been in the cardiac, vascular, and interventional space for over 20 years. He is a Partner with McDermott + Bull Executive Search, recognized by Forbes as one of the industry's best with offices across North America and in Europe. Ken is hired by innovative cardiovascular device and biotech companies to help build their best teams possible at the executive level. Prior to search, Ken had an award winning commercial career at Boston Scientific and Johnson & Johnson to include such prestigious awards as President's Club, Ring Club, and Grand Awards. dropiewski@mbexec.com

Leave a Comment

Your email address will not be published. Required fields are marked *

*